A股减肥药板块短线拉升，丽珠集团涨停，健康元涨超7%，爱美客、博瑞医药涨超6%，翰宇药业、四川双马跟涨。消息面上，世界卫生组织表示，基于GLP-1疗法治疗成人肥胖症的新指南计划9月份正式发布。

Core Viewpoint - The A-share weight loss drug sector experienced a short-term surge, with significant stock price increases for several companies following the announcement of new guidelines for treating adult obesity based on GLP-1 therapy by the World Health Organization, set to be officially released in September [1] Company Performance - Lijun Group reached the daily limit increase in stock price [1] - Health元 saw an increase of over 7% in stock price [1] - Aimeike and Borui Pharmaceutical both experienced stock price increases of over 6% [1] - Hanyu Pharmaceutical and Sichuan Shuangma also followed with price increases [1]